Uncertain times for oral anticoagulation therapy.
Edith A
EA
Nutescu
Ann K
AK
Wittkowsky
William E
WE
Dager
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D001384:Azetidines / Q000008:administration & dosage / Q000009:adverse effects*; D001596:Benzylamines; D017277:Drug Approval; D006801:Humans; D012306:Risk; D014481:United States; D014486:United States Food and Drug Administration; D014859:Warfarin / Q000009:adverse effects
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; C426686:ximelagatran; D014859:Warfarin